Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Austar Lifesciences Ltd. ( (HK:6118) ) just unveiled an announcement.
Austar Lifesciences Limited has announced that its board of directors will hold a meeting on March 26, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The board will also consider recommending a final dividend payment, which could impact the company’s financial strategy and shareholder returns.
More about Austar Lifesciences Ltd.
Austar Lifesciences Limited is a company incorporated in the Cayman Islands, operating within the life sciences industry. It is listed on the Hong Kong Stock Exchange and focuses on providing products and services related to life sciences.
YTD Price Performance: 50.88%
Average Trading Volume: 152,160
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$425.4M
Learn more about 6118 stock on TipRanks’ Stock Analysis page.